JM
Jason McCarthy Maxim Group Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.29 | $4 |
210%
upside
| Buy |
4 Sep ‘25
4 days ago |
|
2
Plus Therapeutics
PSTV
$48.8M
| $0.4914 | $3 |
511%
upside
| Buy |
18 Aug ‘25
21 days ago |
|
3
Reviva Pharmaceuticals
RVPH
$29.9M
| $0.4390 | $2 |
356%
upside
| Buy |
15 Aug ‘25
23 days ago |
|
|
AKTX
4
Akari Therapeutics
AKTX
$26.7M
| $0.8187 | $5 |
511%
upside
| Buy |
18 Jul ‘25
1 month ago |
|
5
SELLAS Life Sciences
SLS
$201M
| $1.91 | $7 |
266%
upside
| Buy |
16 Jul ‘25
1 month ago |
|
6
INmune Bio
INMB
$51.8M
| $1.95 | $8 |
310%
upside
| Buy |
2 Jul ‘25
2 months ago |
|
|
KZIA
7
Kazia Therapeutics
KZIA
$8.67M
| $7.76 | $15 |
93%
upside
| Buy |
11 Jun ‘25
2 months ago |
|
8
Bionano Genomics
BNGO
$18.7M
| $3.99 | $8 |
101%
upside
| Buy |
20 May ‘25
3 months ago |
|
|
MTVA
9
MetaVia Inc. Common Stock
MTVA
$16.7M
| $0.6899 | $3 |
335%
upside
| Buy |
19 May ‘25
3 months ago |
|
10
CERo Therapeutics
CERO
$7.14M
| $5.92 | $60 |
914%
upside
| Buy |
19 May ‘25
3 months ago |
|
11
ProMIS Neurosciences
PMN
$22.3M
| $0.4300 | $3 |
598%
upside
| Buy |
12 May ‘25
3 months ago |
|
|
MDCX
12
Medicus Pharma Ltd. Common Stock
MDCX
$35.2M
| $1.88 | $20 |
964%
upside
| Buy |
8 May ‘25
4 months ago |
|
|
KAPA
13
Kairos Pharma, Ltd.
KAPA
$35.7M
| $1.72 | $4 |
133%
upside
| Buy |
27 Mar ‘25
5 months ago |
|
14
Moleculin Biotech
MBRX
$11.4M
| $0.3750 | $4 |
967%
upside
| Buy |
25 Mar ‘25
5 months ago |
|
15
Anixa Biosciences
ANIX
$95.7M
| $2.97 | $10 |
237%
upside
| Buy |
21 Mar ‘25
5 months ago |
|
|
ONCY
16
Oncolytics Biotech
ONCY
$107M
| $1.06 | $3 |
183%
upside
| Buy |
10 Mar ‘25
6 months ago |
|
|
ABP
17
Abpro Holdings, Inc Common Stock
ABP
$17.2M
| $0.2150 | $4 |
1,760%
upside
| Buy |
24 Feb ‘25
6 months ago |
|
|
IVF
18
INVO Fertility, Inc. Common Stock
IVF
$3.57M
| $0.8190 | $24 |
2,830%
upside
| Buy |
23 Jan ‘25
7 months ago |
|
|
OSTX
19
OS Therapies Incorporated
OSTX
$69.6M
| $2.20 | $15 |
582%
upside
| Buy |
16 Jan ‘25
7 months ago |
|
|
BLTE
20
Belite Bio
BLTE
$2.16B
| $65.74 | $110 |
67%
upside
| Buy |
15 Nov ‘24
9 months ago |
|
21
Indaptus Therapeutics
INDP
$3.65M
| $3.30 | $140 |
4,142%
upside
| Buy |
13 Nov ‘24
9 months ago |
|
22
Quince Therapeutics
QNCX
$86.5M
| $1.61 | $6 |
273%
upside
| Buy |
7 Nov ‘24
10 months ago |
|
|
CMPS
23
Compass Pathways
CMPS
$493M
| $5.14 | $12 |
133%
upside
| Buy |
1 Nov ‘24
10 months ago |
|
24
Annovis Bio
ANVS
$44.6M
| $2.29 | $25 |
992%
upside
| Buy |
25 Oct ‘24
10 months ago |
|
|
AIM
25
AIM ImmunoTech Inc.
AIM
$6.72M
| $2.48 | $1 |
60%
downside
| Buy |
22 Oct ‘24
10 months ago |
|